XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (Unaudited) - USD ($)
shares in Millions, $ in Millions
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Revenues:    
Revenues $ 3,162.1 $ 2,965.1
Expenses:    
Research and development 1,101.2 843.8
Acquired in-process research and development 56.1 28.1
Selling, general, and administrative 601.1 450.0
Other operating (income) expense, net (0.5) (20.2)
Total Expenses 2,215.4 1,706.6
Income from operations 946.7 1,258.5
Other income (expense):    
Other (expense) income, net (70.7) (183.8)
Interest expense (18.0) (13.6)
Total other income (expense) (88.7) (197.4)
Income before income taxes 858.0 1,061.1
Income tax expense 40.2 87.6
Net income $ 817.8 $ 973.5
Net income per share - basic (in dollars per share) $ 7.64 $ 9.12
Net income per share - diluted (in dollars per share) $ 7.17 $ 8.61
Weighted average shares outstanding - basic (in shares) 107.1 106.8
Weighted average shares outstanding - diluted (in shares) 114.0 113.1
Statements of Comprehensive Income    
Net income $ 817.8 $ 973.5
Other comprehensive income (loss), net of tax:    
Unrealized gain (loss) on debt securities 57.2 (144.9)
Unrealized gain on cash flow hedges 0.0 1.0
Comprehensive income 875.0 829.6
Net product sales    
Revenues:    
Revenues 1,668.0 1,638.6
Expenses:    
Cost of goods, collaboration and contract manufacturing 208.4 207.3
Collaboration revenue    
Revenues:    
Revenues 1,378.1 1,232.5
Other revenue    
Revenues:    
Revenues 116.0 94.0
Cost of collaboration and contract manufacturing    
Expenses:    
Cost of goods, collaboration and contract manufacturing $ 249.1 $ 197.6